Neuropathology of Methylmercury Intoxication

  • Takeshi Sato
  • Yasunori Nakamura
Part of the Rochester Series on Environmental Toxicity book series (RSET)

Abstract

The clinical symptoms of methylmercury intoxication, known as Hunter-Russell’s disease and Minamata disease, are characterized by sensory and visual disturbance and cerebellar ataxia. Various animal models have been introduced to study the toxicopathological effects on the nervous system (Berlin et al., 1975). In our previous study (Sato et al., 1976; Sato and Ikuta, 1976), the selective vulnerability of the central nervous system was also demonstrated in monkeys intoxicated with methylmercury. We reported that early changes detected in the nerve cells by electron microscopy were a very sensitive indicator in determining the minimal toxic dose of methylmercury. In this paper we review the minimal toxic dose of methylmercury in monkeys and the selective vulnerability of nerve tissue in experimental animals.
  1. (1)

    To determine the minimal toxic dose of MeHg in monkeys we administered daily 0.2 mg/kg to 4 monkeys for 56–133 days and 0.03 mg/kg to 5 monkeys for 87–331 days. It was demonstrated that 0.03 mg/kg daily (total 3.6–9.0 mg/kg) of MeHg is a toxic enough level to produce ultrastructural changes in the central nervous system.

     
  2. (2)

    To observe early changes in the central nervous system of monkeys and cats intoxicated with low doses of MeHg, an electron microscopic study was carried out and revealed specific ultrastructural changes in the neurons of the lateral geniculate body, calcarme cortex and in the granule cells in the cerebellum.

     
  3. (3)

    In order to ascertain whether the transmitter binding receptor in the central nervous system is affected in cats with or without symptoms, which were administered toxic and subclinical doses of MeHg, we examined the histological alterations associated with MeHg intoxication and then compared these with the influence of MeHg upon the binding of [3H] WB-4101, a potent alpha 1 norepinephrine receptor antagonist, to the occipital cortexes of 7 cats. We found a markedly decreased receptor affinity for alpha 1 norepinephrine in the membrane fraction of the occipital cortex intoxicated with MeHg.

     

Keywords

Purkinje Cell Granule Cell Occipital Cortex Cerebellar Ataxia Lateral Geniculate Body 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Berlin, M., Grant, C.A., Hellberg, J. et al., 1975. Neurotoxicity of methylmercury in squirrel monkeys. Arch. Environ. Health 30:340.PubMedCrossRefGoogle Scholar
  2. Ikeda, Y., Tobe, M., Kobayashi, K. et al., 1973. Long-term toxicity study of methylmercuric chloride in monkeys. Toxicology 1:361.PubMedCrossRefGoogle Scholar
  3. Lapierre, Y., Beaudet, A., Demianczuk, N. et al., 1973. Noradrenergic axon terminals in the cerebral cortex of rat. II. Quantitative data related by light and electron microscope radioautography of the frontal cortex. Brain Res. 63:175.Google Scholar
  4. Sato, T., Makifuchi, T., Ikuta, F. et al., 1976. Long-term studies on the neurotoxicity of small amounts of methylmercury in monkeys, Igaku no Ayumi (in Japanese) 97:75.Google Scholar
  5. Sato, T. and Ikuta, F., 1976. Neuropathology of methylmercury intoxication in Niigata and chronic effects in monkeys. In: Neurotoxicology. L. Roisin, H. Shiraki and N. Grcevic, eds. Raven Press, New York, pp. 261–269.Google Scholar
  6. Takeuchi, T., Etoh, K., Kojima, H. et al., 1972. Minamata disease: Pathological findings in 10-year survivors. Kumamoto Med. J. 46:666.Google Scholar
  7. Tokuomi, H., 1960. Minamata disease: Clinical observation and pathologic physiology. Psychiatr. Neurol. Jpn 62:1816.Google Scholar
  8. Tsubaki, T., Sato, T. et al., 1977. Epidemiology of methylmercury poisoning in Niigata. In: Minamata Disease. T. Tsubaki and K. Irukayama, eds. Kodansha and Elsevier, Tokyo, pp. 56–95.Google Scholar
  9. VonBurg, R., Northington, F.K. and Shamoo, A., 1980. Methylmercury inhibition of rat brain muscarinergic receptors. Toxicol. Appl. Pharmacol. 53:282.Google Scholar
  10. Tsuzuki, Y., 1981. Effects of chronic methylmercury exposure on activities of neurotransmitter enzymes in rat cerebellum. Toxicol. Appl. Pharmacol. 60:379.PubMedCrossRefGoogle Scholar
  11. Yonaha, M., Saito, M. and Sagai, M., 1983. Stimulation of lipid peroxidation by methylmercury in rats. Life Science 32:1507.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1991

Authors and Affiliations

  • Takeshi Sato
    • 1
  • Yasunori Nakamura
    • 1
    • 2
  1. 1.Department of Neurology, School of MedicineJuntendo UniversityTokyoJapan
  2. 2.Department of Dental PharmacologyNippon Dental UniversityNiigataJapan

Personalised recommendations